HOME >> BIOLOGY >> NEWS
The role of phytochromes in bacteria revealed

The phytochromes are photosensitive substances which play an essential role in the various phases of plant development and growth. As photoreceptors they act as sensors that convey information to the plant about changes in ambient light. The two existing forms -active and inactive- can switch one to the other in response to such changes. Under red light they become active and trigger off a cascade of biochemical, in the plant cells to induce processes such as germination, flowering or stem elongation. Although it is well established that phytochromes function like light switches, the chain of biochemical reactions triggered when they are activated are still not well understood. Phytochromes were discovered in bacteria five years ago. However, their role even in these simple organisms has remained difficult to fathom. This has now been partially clarified by researchers from the IRD (Institut de Recherche pour le Dveloppement) and the CEA in conjunction with the CNRS. Their revelatory work has just been published in Nature. The study of bacteriophytochromes might give useful insights into the functional mechanisms of their counterparts in plants.

A research team jointly involving the IRD, the CEA and the CNRS has very recently found phytochromes in a strain of nitrogen-fixing bacterium, Bradyrhizobium (1), symbiont on certain tropical leguminous plants (the Aeschynomene). Techniques of molecular biology, biophysics and biochemistry revealed that the newly-discovered phytochrome has an essential role as regulator of the bacteriums photosystem synthesis. An identical function was shown in the photosynthetic bacterium Rhodopseudomonas palustris, phylogenetically very close to Bradyrhizobium (2).

The researchers experimented by subjecting Bradyrhizobium cells to different wavelengths of light, from the red to the infrared. It appeared that the bacterial photosynthetic apparatus was synthesized in its complete form only when the phytochrome was in its active
'"/>

Contact: Marie Lise Sabrie
sabrie@paris.ird.fr
33-01-48-03-75-36
Institut de Recherche Pour le Dveloppement
13-May-2002


Page: 1 2 3

Related biology news :

1. Researchers find color sensitive atomic switch in bacteria
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
4. Scientists discover potential new way to control drug-resistant bacteria
5. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
6. Missing genes may help explain why plague bacteria are so deadly
7. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
8. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
9. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
10. UV light, coatings reduce bacterial adhesion up to 50 percent
11. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The role phytochromes bacteria revealed

(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
(Date:5/20/2015)... DUBLIN , May 19, 2015 Research and ... addition of the "Global Cell Therapy Market Outlook ... Utilization of cell therapy in tissue and regenerative medicine ... are no other options which could help in the ... in this segment but they are unable to form ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Top Technologies in the Health and Wellness Industry 2015 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: